Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

erest in Zuckerberg and Dorsey." Trump, Ratcliffe Reportedly Seeking Declassification Of Russia Inquiry Document. Reuters (10/22, Hosenball, Bing, Landay) reports President Trump and DNI Ratcliffe "have pushed for quick declassification of a document disputing the 2017 intelligence community finding t

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

/exclusive-trump-u-s- intelligence-chief-push-to-declassify-document-on-russias-2016-election-role-sources-idUSIGEIN2772XG> (10/22, Hosenball, Bing, Landay) reports President Trump and DNI Ratcliffe "have pushed for quick declassification of a document disputing the 2017 intelligence community finding t

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

terest in Zuckerberg and Dorsey." Trump, Ratcliffe Reportedly Seeking Declassification Of Russia Inquiry Document. Reuters (10/22, Hosenball, Bing, Landay) reports President Trump and DNI Ratcliffe "have pushed for quick declassification of a document disputing the 2017 intelligence community finding